COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

THE KRISTEN ANN CARR FUND
NEW YORK, NY · EIN 133800442 · Form 990 · FY2024 · NTEE T31J · Philanthropy & Grantmaking · Small ($100K-$1M) · kristenanncarrfund.org
revenue
$634K
expenses
$1.5M
net assets
$2.7M
employees
0
volunteers
3
program ratio
95%
mission · from form 990

THE KRISTEN ANN CARR FUND PROVIDES GRANTS FOR CANCER RESEARCH AND SEEKS TO IMPROVE ALL ASPECTS OF CANCER PATIENT LIFE WITH EMPHASIS ON ADOLECENTS AND YOUNG ADULTS.

profile · synthesized from sources

The Kristen Ann Carr Fund is a nonprofit foundation established in memory of Kristen Ann Carr, who died of sarcoma at age 24. It supports cancer research and improves the lives of cancer patients, with a focus on adolescents and young adults. The organization funds medical fellowships, research initiatives, and patient support programs, primarily at Memorial Sloan Kettering Cancer Center.

named programs · 6 · from sources

What they call their work

A Night to Remember
Annual gala event that raises funds and awareness for sarcoma research and patient support programs
Kristen Ann Carr Medical Oncology Fellowship
Supports advanced training for medical oncologists focused on sarcoma and cancer care for adolescents and young adults
Kristen Ann Carr Surgical Fellowship
Funds surgical oncology training for physicians specializing in sarcoma treatment, primarily at Memorial Sloan Kettering Cancer Center
Kristen’s Coffee House
Post-treatment resource center offering support and community for cancer survivors at MSKCC
Musicians On Call Partnership
Sponsors virtual bedside performances for patients through the Musicians On Call program
Sunshine Program
Grants wishes to sarcoma patients and their families at Memorial Sloan Kettering Cancer Center
activities · 4 groups

What they do

  • Cancer Research Funding 4 activities
    • Funding cancer research and improving quality of life for adolescent and young adult cancer patients
      Provides grants to support cancer research and initiatives that improve the quality of life for cancer patients, with a focus on adolescents and young adults. This includes funding for both clinical research and patient care programs.
    • Funding infrastructure and specialized facilities for sarcoma research and care
      Provides capital funding to establish dedicated research centers and laboratories for sarcoma, including a $10 million campaign to create The Kristen Ann Carr Sarcoma Center and the Comprehensive Sarcoma Lab at Memorial Sloan Kettering Cancer Center.
    • Funding research into pediatric sarcomas and immunotherapy development
      Supports translational and clinical research on pediatric sarcomas, including studies of immune system interactions with tumor biology, fusion oncoproteins, and the development of novel immunotherapies for Ewing sarcoma, rhabdomyosarcoma, synovial sarcoma, and DSRCT.
    • Funding sarcoma-specific research and treatment initiatives
      Finances research and treatment programs focused on sarcoma, a rare form of cancer, including support for clinical trials, biomarker identification, and therapeutic development targeting specific sarcoma subtypes.
  • Granting Wishes to Seriously Ill Children 1 activity
    • Funding direct patient support services and psychosocial programs
      Finances programs that provide psychosocial and quality-of-life support to sarcoma patients and their families, including funding for a dedicated sarcoma social worker position and the Sunshine Program, which grants wishes for patients at MSKCC.
  • Charitable Grantmaking to Specific Causes 1 activity
    • Funding external organizations and advocacy initiatives in cancer care
      Awards grants to nonprofit organizations such as Planet Cancer, the Sean Kimerling Testicular Cancer Foundation, The Busyhead Project, and supports media projects like the "crazy sexy cancer" documentary to expand awareness and mental health support in the cancer community.
  • Healthcare Education Scholarships and Fellowships 1 activity
    • Funding medical fellowships and training for physician-scientists in oncology
      Awards grants to support the education and training of young physicians and physician-scientists, particularly in sarcoma and rare cancers, through named fellowships at Memorial Sloan Kettering Cancer Center and other institutions. Includes multi-year funding for pediatric, surgical, and medical oncology fellows.
financials · form 990 · fy2024
revenue
Total revenue$634K
Contributions & grants$83K13%
Program service revenue$00%
Investment income$94K15%
Other revenue$458K
expenses
Total expenses$1.46M
Program expenses95%
Admin / overhead4%
Fundraising1%
Salaries & benefits$0
Grants paid out$1.36M
Largest expense lineProfessional Fees
balance sheet
Total assets$2.69M
Cash$566K
Investments$2.12M
Liabilities$0
Net assets$2.69M
Liquid reserves22.1 mo
4 years on record · 2020–2024 · YoY revenue -36.3%
leadership · form 990 part vii · fy2024

Who runs it

board members · 3
  • BARBARA MARSH — TRUSTEE
  • DAVID MARSH — TRUSTEE
  • MICHAEL SOLOMON — TRUSTEE
relationships · 54

Who they work with

  • Atlantic Surgical Oncology Partner — Host institution for a funded surgical fellow.
  • Bar Primi Partner — Culinary partner contributing to the annual benefit event.
  • Children's Hospital of Philadelphia Partner — Host institution for a funded pediatric medical oncology fellow.
  • Cleveland Clinic Abu Dhabi Partner — Host institution for a funded surgical fellow.
  • Cycle For Survival Partner — KACF organizes an annual team ride for this fundraising event focused on rare cancer research.
  • Drew Nieporent’s The Daily Burger Partner — Culinary partner contributing to the annual benefit event.
  • Geisel School of Medicine, Dartmouth Partner — Host institution for a funded surgical fellow.
  • Gerald J. & Dorothy R. Friedman New York Foundation for Medical Research Partner — Funding partner supporting medical research initiatives.
  • HBO Partner — Media and content partner in awareness and storytelling initiatives.
  • Hard Rock Cafe International Partner — Supports fundraising and awareness efforts through hospitality and event partnerships.
  • Indiana University School of Medicine Partner — Host institution for a funded surgical fellow.
  • Jennifer Schloss, MD, PhD Partner — Kristen Ann Carr Fund Pediatric Oncology Fellow conducting research on pediatric sarcomas.
  • Lafayette Partner — Culinary partner contributing to the annual benefit event.
  • Locanda Verde Partner — Culinary partner contributing to the annual benefit event.
  • MTV Partner — Media partner in promoting awareness and engagement around the fund’s mission.
  • Madison Square Garden Partner — Partner in hosting events and raising awareness for cancer research and patient life improvement.
  • Massachusetts General Hospital Partner — Host institution for a funded surgical fellow.
  • Memorial Sloan Kettering Partner — Hosts KACF Fellows conducting sarcoma research supported by the fund.
  • Memorial Sloan Kettering Cancer Center Partner — Collaborates with MSKCC to treat all sarcoma patients through The Kristen Ann Carr Sarcoma Center.
  • Memorial Sloan Kettering Cancer Center Partner — Host institution for multiple fellows supported by the fund.
  • Memorial Sloan Kettering Cancer Center Partner — Host institution for the Kristen Ann Carr Fellows training program.
  • Memorial Sloan Kettering Cancer Center Partner — Hosts the Kristen Ann Carr Fund Surgical Oncology Fellow for clinical and research training in sarcoma.
  • Memorial Sloan Kettering Cancer Center Partner — Hosts the funded oncology fellowship program for sarcoma and early drug development.
  • Memorial Sloan Kettering Cancer Center Partner — Longstanding partner where KACF funds programs including a sarcoma social worker, the Sunshine Program, and research initiatives.
  • Memorial Sloan Kettering Cancer Center Partner — Primary institution for KACF-funded sarcoma research, fellowships, and clinical care
  • Musicians On Call Partner — Collaborates on programs that bring music to patients in healthcare settings.
  • NOBU Partner — Culinary partner contributing to the annual benefit event.
  • NOHO Hospitality Partner — New partner providing culinary services for the annual benefit event.
  • NYU Langone/NYU Grossman School of Medicine Partner — Host institution for a funded surgical fellow.
  • Noah Kahan's The Busyhead Project Partner — Funded to launch a statewide Mental Health Initiative in Vermont.
+ 24 more
strategies · 4

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Age-Specific and Disease-Targeted Grantmaking
    methodology: age-specific_grantmaking
    By focusing grantmaking on adolescents and young adults with sarcoma, the organization addresses unique biological and psychosocial challenges in this population, accelerating research and care improvements where needs are unmet. This dual specificity increases the relevance and impact of funded interventions.
  • Integration of Research and Clinical Care to Accelerate Treatment Advances
    methodology: translational_research_collaboration
    By funding dedicated centers and fostering translational research collaborations, the organization bridges laboratory science and clinical investigation, enabling faster development and implementation of effective sarcoma treatments because discovery and application occur in parallel.
  • Investing in Specialized Training to Build Expertise in Sarcoma Care
    methodology: specialized_fellowship_training
    By endowing surgical and medical oncology fellowships, the organization strengthens the pipeline of specialists trained in sarcoma treatment, ensuring sustained advances in clinical care because expert providers are essential to translating research into practice.
  • Leveraging Advanced Analytics and AI to Improve Cancer Outcomes
    methodology: ai-driven-oncology-research
    By applying artificial intelligence, real-world data, and clinical epidemiology, the organization enhances prognostic modeling, risk stratification, and treatment decision-making in rare sarcomas, overcoming limitations of sparse clinical trial data and enabling more personalized, evidence-based care.